Abstract:BackgroundPatient-derived tumor models are the new standard for pre-clinical drug testing and biomarker discovery. However, the emerging technology of primary pancreatic cancer organoids has not yet been broadly implemented in research, and complex organotypic models using organoids in co-culture with stromal and immune cellular components of the tumor have yet to be established. In this study, our objective was to develop and characterize pancreatic cancer organoids and multi-cell type organotypic co-culture models to demonstrate their applicability to the study of pancreatic cancer.MethodsWe employed organoid culture methods and flow cytometric, cytologic, immunofluorescent and immunohistochemical methods to develop and characterize patient-derived pancreatic cancer organoids and multi-cell type organotypic co-culture models of the tumor microenvironment.ResultsWe describe the culture and characterization of human pancreatic cancer organoids from resection, ascites and rapid autopsy sources and the derivation of adherent tumor cell monocultures and tumor-associated fibroblasts from these sources. Primary human organoids displayed tumor-like cellular morphology, tissue architecture and polarity in contrast to cell line spheroids, which formed homogenous, non-lumen forming spheres. Importantly, we demonstrate the construction of complex organotypic models of tumor, stromal and immune components of the tumor microenvironment. Activation of myofibroblast-like cancer associated fibroblasts and tumor-dependent lymphocyte infiltration were observed in these models.ConclusionsThese studies provide the first report of novel and disease-relevant 3D in-vitro models representing pancreatic tumor, stromal and immune components using primary organoid co-cultures representative of the tumor-microenvironment. These models promise to facilitate the study of tumor-stroma and tumor-immune interaction and may be valuable for the assessment of immunotherapeutics such as checkpoint inhibitors in the context of T-cell infiltration.

Bioengineering Approaches for the Pancreatic Tumor Organoids Research and Application

Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?

[Application and research progress of patient-derived organoids in the multimodality treatment of pancreatic cancer]

A Prospective Advanced Model for Pancreatic Cancer Research

A Pancreas Tumor Derived Organoid Study: from Drug Screen to Precision Medicine

The application of pancreatic cancer organoids for novel drug discovery

Engineering of biomaterials for tumor modeling

Advancing cancer research through organoid technology

Organoid model: A new hope for pancreatic cancer treatment?

Organoids: approaches and utility in cancer research

Ultrasound-guided fine-needle aspiration/biopsy-based pancreatic organoids establishment: an alternative model for basic and preclinical research

Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring

Organoid Models of Human and Mouse Ductal Pancreatic Cancer

Research Status and Application Prospect of Personalizing Pancreatic Cancer Organoids in The Era of Precision Medicine

Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy

Construction of tumor organoids and their application to cancer research and therapy

Progress and perspective of organoid technology in breast cancer research

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models

Pancreatic Organoids: A Frontier Method for Investigating Pancreatic-Related Diseases

Flourishing tumor organoids: History, emerging technology, and application

Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer